anmelden
25 € WM-Startbonus + 5 € Torbonus für jeden deutschen Treffer*
SPI
19.954,36
PKT
-96,42
PKT
-0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.01.12 | Komax buy | Sarasin Research | |
| 17.01.12 | Novartis buy | Nomura | |
| 17.01.12 | Implenia buy | Vontobel Research | |
| 17.01.12 | Komax hold | Vontobel Research | |
| 17.01.12 | SGS SA buy | Vontobel Research | |
| 17.01.12 | Barry Callebaut hold | Vontobel Research | |
| 17.01.12 | Huber + Suhner hold | Vontobel Research | |
| 17.01.12 | COLTENE hold | Vontobel Research | |
| 17.01.12 | Galenica hold | Vontobel Research | |
| 17.01.12 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
| 16.01.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | Nestlé buy | UBS AG | |
| 16.01.12 | Partners Group overweight | Morgan Stanley | |
| 16.01.12 | Nestlé hold | Vontobel Research | |
| 16.01.12 | Lindt hold | Vontobel Research | |
| 16.01.12 | Holcim hold | Vontobel Research | |
| 16.01.12 | Novartis buy | WestLB AG | |
| 16.01.12 | Zurich Insurance buy | Citigroup Corp. | |
| 16.01.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 16.01.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 13.01.12 | UBS neutral | UBS AG | |
| 13.01.12 | Holcim hold | Deutsche Bank AG | |
| 13.01.12 | Holcim buy | Deutsche Bank AG | |
| 13.01.12 | Novartis buy | Sarasin Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Sarasin Research | |
| 13.01.12 | OC Oerlikon buy | Vontobel Research | |
| 13.01.12 | Geberit buy | Vontobel Research | |
| 13.01.12 | Avolta (ex Dufry) buy | Société Générale Group S.A. (SG) | |
| 13.01.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 13.01.12 | Cicor Technologies buy | Vontobel Research | |
| 13.01.12 | Novartis hold | Vontobel Research | |
| 13.01.12 | Komax neutral | Banc of America Securities-Merrill Lynch | |
| 12.01.12 | Swatch (I) overweight | HSBC | |
| 12.01.12 | Givaudan sell | Citigroup Corp. | |
| 12.01.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 12.01.12 | Novartis buy | Nomura | |
| 12.01.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 12.01.12 | Roche neutral | Nomura | |
| 12.01.12 | Sulzer buy | Sarasin Research |